From pipeline to patient: How Ready-to-Use vials can accelerate the drug development process
Ready-to-Use products offered as particulate cleaned, depyrogenated and sterile primary packaging components are experiencing a rapid market adoption. Ready-to-Use vials in particular have the ability to accelerate traditional drug development journeys and support pharmaceutical and biotechnology companies in meeting the growth in demand for personalized medicines and biologics.
In this webinar, DWK Life Sciences has teamed up with Avantor to provide insight on:-
- The role Ready-to-Use vials can play in improving flexibility, efficiency and patient safety
- How a strategic partnership between DWK Life Sciences and Stevanato Group has increased the availability of the world’s most widely adopted Ready-to-Use vial standard, Stevanato Group’s EZ-fill® vials
- How this increased availability benefits the development phase, technology transfer and commercialization of new drugs at early stages
For more information, please contact us at email@example.com.